Local 12: UC researchers study how to personalize COVID-19 treatments
The University of Cincinnati's Bingfang Yan, PhD, DVM, has received a $2.5 million National Institutes of Health grant to study how currently approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
“The question we are asking is, can we combine two of those, or even three of those, that can produce better favor or more effective treatment?" Yan, professor and associate dean for research and innovation at UC's James L. Winkle College of Pharmacy, told Local 12 News.
Yan said finding out more about how these drugs can be given in combination will not only help treat COVID, but may be useful in treating other viruses like influenza.
Yan also spoke about the research on 55KRC's Simply Medicine radio show and podcast. Listen to the Simply Medicine interview. (Note: Segment begins around 17:55 mark of episode.)
Featured photo at top of remdesivir in an IV bag. Photo/Dimitri Karastelev/Unsplash.
Related Stories
A family tradition continues at UC College of Nursing
April 24, 2026
When Ashley Enginger walks across the stage at this spring’s commencement ceremony, she will leave behind a UC College of Nursing that her family is far from finished with. Her sister Sarah is already two years in, and their youngest sister Lauren is set to arrive in the fall.
Rain, steep slopes put NY community at risk of landslides, geologist warns
April 23, 2026
UC Associate Professor Dan Sturmer tells News10 that heavy rain combined with steep slopes is a recipe for landslides in one New York community.
UC expands partnership with Thales for AI research
April 22, 2026
The University of Cincinnati’s interdisciplinary research facility Digital Futures welcomed its first industrial partner, Thales, at the beginning of Research + Innovation week. Thales is a global aerospace, defense and digital technology firm. Headquartered in France, it employs 83,000 people in dozens of countries, according to the Business Courier.